Gala GLP-1 vs Ivim Health: Real Costs, Risks, and the Honest Verdict (2026)
We may earn a commission if you sign up through some links on this page. We have no affiliate relationship with Ivím Health. Our verdicts are based on verified facts, not commission rates. Compounded GLP-1 medications are not FDA-approved finished drug products. Prescription required after clinical evaluation; not all patients qualify. This page is not medical advice.
The Bottom Line on Gala GLP-1 vs Ivim Health
Gala GLP-1 — lower friction, single subscription price
If you want a simpler self-pay path with one subscription price and access in all 50 states, Gala is the lower-friction pick. Gala publicly advertises $179/month for compounded GLP-1/GIP on a yearly subscription, $199/month on its 3-month plan, and $149/month on a separate microdosing track. Final pricing confirmed at checkout.
Ivím Health — higher-touch care, multi-month commitment
If you can commit to a longer plan and want weekly provider check-ins, brand-name medication options, and unlimited visits, Ivím Health is the more involved option — but the real cost is the medication package plus a $74.99/month program fee, and Ivím received an FDA warning letter on February 20, 2026 for misbranding tied to false or misleading compounded GLP-1 website labeling.
Neither — consider Ro if you want FDA-approved brand-name medication
If what you actually want is FDA-approved Wegovy®, Zepbound®, Ozempic®, or Foundayo™ with insurance support, neither Gala nor Ivim is the cleanest regulatory path. Ro is built specifically around this.
Prescription required after clinical review; final price confirmed at checkout. Sponsored affiliate link.
6 questions. Matches you to the GLP-1 program that fits your budget, state, and goals.
At-a-Glance: Gala GLP-1 vs Ivím Health
| Factor | Gala GLP-1 | Ivím Health |
|---|---|---|
| Headline price (compounded) | $179/mo yearly subscription; $199/mo on 3-month plan; $149/mo microdosing track | Semaglutide $379 for 2 months or $499 for 4 months; GLP-1 ID semaglutide from $149/mo (med + fee) |
| Tirzepatide / GLP-1+GIP | Bundled into GLP-1/GIP offering at prices above | $550 for 2 months or $900 for 4 months; GLP-1 ID tirzepatide from $224/mo (med + fee) |
| Separate program/membership fee | None disclosed beyond subscription price | $74.99/month program fee · First month free |
| Brand-name medications | Compounded is the lead track; brand-name referenced on site | Wegovy®, Zepbound®, Ozempic®, Mounjaro®, Saxenda® when medically appropriate |
| Compounded medication status | Not FDA-approved | Not FDA-approved |
| States served | All 50 states (provider-stated) | 49 states + DC (no Mississippi) |
| Cancellation | Cancel any time; must request ≥72 hours before billing; no refund except medical disqualification | No mid-term cancellation on multi-month plans; request ≥48 hours before renewal |
| Medication refunds | Full refund only if medically disqualified | Prescribed medications non-refundable |
| Trustpilot (verified May 17, 2026) | 4.7 · ~2,992 reviews · 85% 5-star · 5% 1-star | 4.9 · ~37,232 reviews · 94% 5-star · 2% 1-star |
| Negative-review response | 51% reply rate · typically within 1 month | 99% reply rate · typically within 24 hours |
| BBB profile | F rating · not accredited · 15 complaints, 15 unanswered | A+ rating · accredited since 2/28/2023 · 100 complaints in 3 years, 63 closed in 12 months |
| Published clinical study | None we verified | Duncan et al., Obesity Pillars, 2025 — 1,131 patients, ~21.8% total body weight loss at 68 weeks (observational, not randomized) |
| FDA warning letter | None found in FDA database as of May 17, 2026 | Yes — Feb 20, 2026 (misbranding/labeling, FDCA §§ 502(a) and 502(bb)) |
Pricing and ratings verified May 17, 2026. Verify final cost at checkout — provider terms and promotions can change.
Who Should Pick What — the 30-Second Decision
Pick Gala GLP-1 if you:
- ✓Want a single subscription price with no separate program fee
- ✓Need flexibility to cancel before any billing cycle (72-hour deadline)
- ✓Live in Mississippi (Ivím does not serve it)
- ✓Want a compounded GLP-1/GIP option without multi-month commitment math
- ✓Prefer a lighter-touch async support model
Sponsored affiliate link.
Pick Ivím Health if you:
- ✓Can commit to a multi-month medication plan upfront
- ✓Want weekly provider check-ins and unlimited visits
- ✓Want a real path to FDA-approved brand-name medication with PA support
- ✓Are comfortable with the Feb 2026 FDA misbranding letter context
Not an affiliate link.
Pick Ro instead if you:
- ✓Want FDA-approved Wegovy®, Zepbound®, Foundayo™, Ozempic®, or Mounjaro®
- ✓Want insurance prior-authorization support
- ✓Want the cleanest regulatory path in telehealth GLP-1
$39 first month. Sponsored affiliate link.
6 questions. Matches you to the GLP-1 program that fits your budget, state, and goals.
What We Actually Verified for This Page
This is not a press-release summary. Here is the source ledger — Last verified: .
| Fact | Source | Date | Notes |
|---|---|---|---|
| Gala $179/mo yearly-subscription price | galaglp1.com homepage | May 17, 2026 | Tied to yearly-subscription disclaimer |
| Gala $199/mo on 3-month plan ($597 total) | galaglp1.com FAQ | May 17, 2026 | Final pricing confirmed at checkout |
| Gala $149/mo microdosing GLP-1/GIP | galaglp1.com homepage | May 17, 2026 | Plan length and total due verified at checkout |
| Gala 72-hour cancellation rule | galaglp1.com refund policy | May 17, 2026 | Cancellation does not create refund except medical disqualification |
| Gala BBB profile | bbb.org | May 17, 2026 | AI Coaching Inc. dba Gala GLP-1; F rating, not accredited, 15 complaints unanswered |
| Ivím compounded semaglutide ($379/$499) | ivimhealth.com/glp1-pricing/ | May 17, 2026 | Membership required after first free month |
| Ivím compounded tirzepatide ($550/$900) | ivimhealth.com/glp1-pricing/ | May 17, 2026 | Membership required after first free month |
| Ivím GLP-1 ID starting prices (sema $149/mo, tirz $224/mo) | ivimhealth.com GLP-1 ID pages | May 17, 2026 | Medication + program fee included; verify plan terms at checkout |
| Ivím $74.99/mo program fee | ivimhealth.com homepage | May 17, 2026 | First month free |
| Ivím cancellation rules | ivimhealth.com subscription pages | May 17, 2026 | No mid-term cancellation; 48 hours before renewal |
| Ivím BBB profile | bbb.org | May 17, 2026 | A+ rating, accredited since 2/28/2023; 100 complaints in 3 years, 63 closed in 12 months |
| Ivím state availability (49 states + DC) | ivim.zendesk.com help center | Source last updated Jan 7, 2025 | Excludes Mississippi |
| FDA warning letter to Ivim Services LLC | fda.gov warning letter database | Letter dated Feb 20, 2026 | Misbranding, FDCA §§ 502(a) and 502(bb) |
| Ivím Duncan et al. study (~21.8% TBW loss at 68 weeks) | Obesity Pillars, 2025; Ivím research page | May 17, 2026 | Provider-published observational study; not randomized; not a head-to-head trial |
| Trustpilot ratings (Gala ~2,992 / Ivím ~37,232) | trustpilot.com | May 17, 2026 | TrustScores and response rates verified |
| FDA adverse-event reports (compounded GLP-1) | fda.gov | As of July 31, 2025 | 605 compounded semaglutide and 545 compounded tirzepatide reports; underreporting likely |
| FDA 503B bulks list proposal (April 2026) | fda.gov press announcement | April 2026 | Public comment closes June 29, 2026 |
| Ro Body pricing | ro.co/weight-loss/pricing/ | May 17, 2026 | $39 first month, $149/mo or as low as $74/mo with annual plan; medication billed separately |
What we did not do: We did not prescribe, dispense, or use either provider's medication. We're not licensed clinicians. This page is an editorial comparison, not medical advice.
How Much Does Gala GLP-1 vs Ivím Health Really Cost?
Gala publicly shows three prices depending on plan: $179/month on a yearly subscription, $199/month on a 3-month plan (about $597 total), and $149/month for a separate microdosing track. Ivím splits cost into a medication package plus a $74.99/month program fee starting in month 2. On Ivím's 4-month semaglutide package ($499 medication + 3 months of program fee), the all-in works out to about $724 total or about $181 per month.
Gala GLP-1 pricing
- $179/month — yearly subscription, compounded GLP-1/GIP
- $199/month — 3-month plan ($597 total)
- $149/month — separate microdosing GLP-1/GIP track; verify plan length at checkout
- No separate program fee beyond the subscription price. Plan on $149–$199/month depending on plan and track. Final pricing confirmed at checkout.
Ivím Health pricing
- Semaglutide packages: $379 for 2 months or $499 for 4 months
- Tirzepatide packages: $550 for 2 months or $900 for 4 months
- GLP-1 ID semaglutide: from $149/month (medication + program fee)
- GLP-1 ID tirzepatide: from $224/month (medication + program fee)
- Program fee: $74.99/month starting in month 2. First month free. Brand-name medications (Wegovy®, Zepbound®, etc.) also available.
The Verified All-In Math
| Scenario | Medication | Program fee | Total | Per month |
|---|---|---|---|---|
| Gala — 3-month plan ($199/mo) | $597 (3 × $199) | $0 | $597 | ~$199 |
| Gala — yearly subscription public price | $179/mo public price | $0 | Verify total at checkout | ~$179 |
| Gala — microdosing GLP-1/GIP | $149/mo public price | $0 | Verify total at checkout | ~$149 |
| Ivím — 2-month semaglutide package | $379 | $75 (month 2) | $454 | ~$227 |
| Ivím — 4-month semaglutide package | $499 | $225 (months 2–4) | $724 | ~$181 |
| Ivím — 2-month tirzepatide package | $550 | $75 (month 2) | $625 | ~$313 |
| Ivím — 4-month tirzepatide package | $900 | $225 (months 2–4) | $1,125 | ~$281 |
| Ivím — GLP-1 ID semaglutide starting price | $149/mo (med + fee) | (included) | Verify plan term at checkout | ~$149 |
| Ivím — GLP-1 ID tirzepatide starting price | $224/mo (med + fee) | (included) | Verify plan term at checkout | ~$224 |
Takeaway:
· For 3-month commitments, Gala's $199/mo plan is cheaper than Ivím's 2-month packages.
· On Ivím's 4-month semaglutide package, the all-in is about $181/mo — close to Gala's yearly-subscription price.
· For tirzepatide / GLP-1+GIP without a long commitment, Gala is materially cheaper than Ivím's 2-month package ($313/mo) and meaningfully cheaper than the 4-month ($281/mo).
The headline price isn't the price. The plan length is the price.
Prescription required after clinical review; final price confirmed at checkout. Sponsored affiliate link.
Are Gala and Ivím Compounded GLP-1 Medications FDA-Approved?
What "compounded" means
A compounding pharmacy is a licensed pharmacy that prepares custom medication on a prescription-by-prescription basis. 503B outsourcing facilities are inspected by the FDA — but the medications they prepare are not the same as FDA-approved finished drug products like Wegovy® or Zepbound®, which go through full FDA review for safety, manufacturing, and effectiveness.
Compounded does not automatically mean unsafe. It does mean the finished drug has not been reviewed by the FDA for safety, effectiveness, or quality. The FDA has also reported adverse events involving compounded semaglutide and compounded tirzepatide — 605 compounded semaglutide reports and 545 compounded tirzepatide reports as of July 31, 2025 — while noting underreporting is likely.
What Gala discloses
Gala's terms say compounded GLP-1 medications are not FDA-approved and are sourced from licensed compounding pharmacies. Gala also references brand-name medication options on its site, but its lead offering is compounded.
What Ivím discloses
Ivím's pricing page says compounded medications are not FDA-approved and have not been reviewed by the FDA for safety, effectiveness, or quality. Ivím does offer FDA-approved brand-name medications when a provider determines they're appropriate, and the company submits prior-authorization paperwork for many private insurance plans (generally not Medicare or Medicaid).
The honest takeaway
If you specifically want FDA-approved brand-name medication, neither Gala nor Ivím is the cleanest path. Ro publicly carries Zepbound® (tirzepatide) and Foundayo™ (orforglipron) and other FDA-approved options, matches LillyDirect / NovoCare pricing for cash-pay FDA-approved GLP-1s, runs an insurance concierge, and offers a free GLP-1 Insurance Coverage Checker.
Insurance support depends on medication and plan. Sponsored affiliate link.
What About Ivím Health's FDA Warning Letter?
Quick answer:
On February 20, 2026, the FDA sent a warning letter to Ivim Services LLC for misbranding under sections 502(a) and 502(bb) of the Federal Food, Drug, and Cosmetic Act, tied to false or misleading compounded GLP-1 website labeling and marketing. The letter is not a recall, not a contamination finding, not a sterility finding, and does not allege a specific patient was harmed — but it is a real public regulatory record, and you should hear about it from us before you sign up.
What the FDA actually said
The FDA reviewed Ivím's website in December 2025 and observed compounded semaglutide and tirzepatide products offered for sale. The agency raised concerns under FDCA sections 502(a) and 502(bb): the specific finding was that the pictured labels on Ivím's website displayed "Ivim" on the packaging, which the FDA said falsely suggested Ivím itself was the compounder when in fact Ivím partners with separate compounding pharmacies. The FDA gave Ivím 15 working days to respond.
What the letter does and does not prove
| What the letter IS | What the letter is NOT |
|---|---|
| A public misbranding finding tied to website labeling and marketing | A recall |
| A finding under FDCA §§ 502(a) and 502(bb) | A contamination or sterility finding |
| A regulatory action against Ivim Services LLC | An allegation that a specific patient was harmed |
| Part of a coordinated CDER enforcement sweep (29 letters issued Feb 20, 2026) | An assertion that compounded medications dispensed through Ivím are inherently unsafe |
Why this matters anyway
Two reasons. First, this is a public regulatory record that will continue to appear in search results. Second, the broader regulatory environment is in motion: in April 2026, the FDA proposed not to include semaglutide, tirzepatide, or liraglutide on the 503B bulks list — the list of substances 503B outsourcing facilities are allowed to compound. The public comment period closes June 29, 2026. If finalized, compounded GLP-1 access could narrow further.
Did Gala get a warning letter too?
As of May 17, 2026, we found no FDA warning letter against Gala GLP-1 (AI Coaching Inc.) in the FDA's public warning letter database. We will re-verify monthly and update this page if anything changes.
Our honest read
If FDA regulatory cleanliness is your top concern, neither compounded provider is the cleanest regulatory path — the cleaner answer is the FDA-approved route through Ro. If you're comfortable with the broader compounded category and want the higher-touch option, Ivím's misbranding letter doesn't disqualify it for most readers, but it belongs in your decision.
Insurance concierge and free coverage checker included. Sponsored affiliate link.
Which Pharmacy Actually Dispenses the Medication?
Neither Gala nor Ivím compounds medications themselves. Both are telehealth platforms that connect you with a licensed provider and route the prescription to a separate compounding pharmacy. Before you pay either provider, you should know which pharmacy will dispense your specific medication.
Gala's dispensing model
Gala's terms describe it as a telehealth platform. Licensed providers affiliated with independently-operated medical practices (Gala references OpenLoop-affiliated and other medical groups) prescribe medications, and partner compounding pharmacies dispense them. Gala says it works with a nationwide network of pharmacies.
Ivím's dispensing model
Ivím partners with 503A and 503B compounding pharmacies that follow United States Pharmacopeia (USP) standards. Brand-name FDA-approved medications dispensed through Ivím are sent to a local retail pharmacy for pickup; compounded medications are shipped directly to you.
Ask before paying — for both providers:
- 1. The exact dispensing pharmacy name
- 2. Whether it's a 503A or 503B pharmacy
- 3. Whether it's licensed to ship to your state
- 4. Whether you can request a Certificate of Analysis (batch testing document) for your medication
The platform name on your account isn't what matters most. The pharmacy name on your bottle does.
Which One Has Better Support and Care?
Ivím's care model (higher-touch)
- ✓Unlimited medical care through the app
- ✓Video or chat visit at intake
- ✓Weekly check-ins under Ivím's GLP-1 ID titration protocol — providers adjust dose based on weekly reports, not a fixed schedule
- ✓24/7 text and call support per Ivím's public pages
- ✓Coaching and community features
- ✓Nutrition and lifestyle guidance
- ✓Nearly 100 medical providers including Obesity Medicine Physicians and Nurse Practitioners (Ivím-stated)
Gala's care model (lighter-touch)
- ✓Licensed provider review at intake
- ✓Async messaging with providers for dose questions and adjustments
- ✓Companion app for tracking shots, weight, and side effects
- ✓Free shipping included in the subscription
- ✓No separate program fee — support is bundled into the subscription price
The damaging admission (and why it might not matter to you)
Gala does NOT offer weekly video check-ins or unlimited live provider visits. If clinical hand-holding is the difference between sticking with your program or quitting, Ivím is structurally the better fit, and you should pick Ivím. But because Gala skips the high-touch care model, it can hold the all-in price at $149–$199 per month with no separate program fee — which is the right tradeoff for someone who has done GLP-1 before, knows what to expect, and just wants a clean self-pay path.
Prescription required after clinical review. Sponsored affiliate link.
Are Gala GLP-1 and Ivím Health Legit? Real Reviews, Real Data
Trustpilot snapshot (verified May 17, 2026)
| Metric | Gala GLP-1 | Ivím Health |
|---|---|---|
| TrustScore | 4.7 | 4.9 |
| Total reviews | ~2,992 | ~37,232 |
| 5-star share | 85% | 94% |
| 1-star share | 5% | 2% |
| Negative-review response rate | 51% | 99% |
| Typical negative-review response time | Within 1 month | Within 24 hours |
BBB profiles (verified May 17, 2026)
Gala (AI Coaching Inc. dba Gala GLP-1)
F rating — not BBB accredited
BBB cites failure to respond to 15 complaints, with 15 complaints filed. This is a real, material trust signal about complaint handling — not about medication safety. BBB ratings reflect a company's responsiveness and complaint history with BBB itself. For a YMYL provider, leaving complaints unanswered is a real factor in the trust profile.
Ivím (Ivim Services LLC, Columbus OH)
A+ rating — accredited since 2/28/2023
100 total complaints in the last 3 years; 63 closed in the last 12 months. Complaint handling pattern is active and documented.
Review pattern matrix
| Pattern | Gala GLP-1 | Ivím Health |
|---|---|---|
| Positive patterns | Convenience, fast shipping, in-app tracking, lower cost vs larger competitors | Weekly check-ins, provider quality, community/coaching features, structured titration |
| Negative patterns | Refund disputes (72-hour billing cutoff), occasional dosage-ceiling gaps on tirzepatide, microdose track confusion | Surprise at $74.99/month program fee on top of medication, mid-term cancellation lock-in, occasional shipping delays |
| Volume signal | Smaller (~2,992 reviews) — interpret with smaller-sample caution | Much larger (~37,232 reviews) — operational pattern is more visible |
| Negative-review response | 51% reply rate, typically within 1 month | 99% reply rate, typically within 24 hours |
| BBB complaint pattern | F rating, 15 unanswered complaints | A+ rating, 100 complaints in 3 years, active resolution pattern |
| Practical buyer risk | Watch the 72-hour cancellation deadline and the BBB responsiveness signal | Watch the multi-month plan lock-in and the FDA misbranding letter |
Gala — positive (paraphrased, Trustpilot 2026)
"A reviewer praised Gala for excellent support, fast shipping, and a meaningfully lower price than the previous provider they used."
Customer review describes individual service experience.
Gala — critical (paraphrased, Trustpilot 2026)
"A reviewer described frustration over an unexpected charge after they thought they had canceled, citing difficulty reaching support before the next billing cycle."
Customer review describes individual service experience.
Ivím — positive (paraphrased, Trustpilot 2026)
"An Ivím patient described their nurse practitioner as thorough, attentive, and the reason they stayed consistent with weekly check-ins."
Customer review describes individual service experience.
Ivím — critical (paraphrased, Trustpilot 2026)
"A reviewer was caught off guard by the $74.99/month program fee on top of the medication price and felt the all-in cost was harder to estimate upfront than the ads suggested."
Customer review describes individual service experience.
Customer reviews describe individual experiences with service, billing, support, shipping, or communication. They do not prove safety, effectiveness, or typical weight-loss results.
How Does Cancellation Work — and What Happens If I Want My Money Back?
This is the section that prevents the most "I wish I'd known" emails.
Gala cancellation rules
- ✓Cancel any time through the app or by contacting support
- !Request must be made at least 72 hours before your next billing date — otherwise the next cycle bills
- !Full refund only if a provider determines you're medically disqualified from treatment
- ✗Cancellation itself does not automatically trigger a refund of the current billing cycle
Ivím cancellation rules
- ✗You cannot cancel mid-term. If you commit to a 2-, 4-, 6-, or 12-month medication plan, you're a member through the end of that plan period
- !Cancellation requests must be made at least 48 hours before renewal
- !The $74.99/month program fee can be canceled separately, but the medication plan still runs its term
- ✗Prescribed medications are non-refundable per Ivím's refund policy
Translation for your decision:
· Want to try GLP-1 without locking in a multi-month plan → Gala (mind the 72-hour cancellation deadline)
· Can commit to a 4-month or longer plan and want the structured care model → Ivím (mind the no-mid-term-cancellation rule)
Prescription required after clinical review. Sponsored affiliate link.
Compounded Semaglutide vs Compounded Tirzepatide — Which Provider Is Better for Which?
A licensed clinician decides which medication is right for you. We're showing you the cost math so you walk in informed.
Semaglutide buyers
- · Ivím 4-month: ~$181/mo all-in
- · Ivím 2-month: ~$227/mo all-in
- · Ivím GLP-1 ID from: ~$149/mo (verify term)
- · Gala 3-month plan: $199/mo
- · Gala yearly subscription: $179/mo (verify terms)
If committing to 4+ months and certain semaglutide is your medication, Ivím can match or slightly beat Gala. Shorter commitment → Gala wins.
Tirzepatide / GLP-1+GIP buyers
- · Gala 3-month: $199/mo for GLP-1/GIP
- · Gala yearly: $179/mo (verify terms)
- · Ivím 4-month: ~$281/mo all-in
- · Ivím 2-month: ~$313/mo all-in
- · Ivím GLP-1 ID from: ~$224/mo
Gala is meaningfully cheaper on tirzepatide at every comparable plan length.
Microdosing buyers
Gala offers a separate microdosing GLP-1/GIP track at $149/month public price.
Honest flag:
Some Trustpilot reviewers report being prescribed a microdose without enough context about what microdosing is typically used for (it's more often a maintenance protocol than an initial weight-loss protocol). If your provider recommends a microdose, ask whether it's an appropriate starting strategy for your specific goals.
Methodology — How We Scored Gala vs Ivím
We weighted categories based on what actually changes the buying decision for cash-pay GLP-1 shoppers.
| Category | Weight | Why it matters |
|---|---|---|
| All-in price (with fees) | 20% | Headline pricing misleads when program fees or plan terms are separate |
| Price transparency | 15% | Hidden fees are the #1 trust-killer in telehealth GLP-1 |
| Clinical support depth | 15% | Some people quit when support is too light; others quit when it's too much |
| Cancellation / commitment friction | 15% | Multi-month lock-ins are real subscription risk |
| Regulatory standing | 15% | FDA actions are public and durable |
| Review profile & responsiveness | 10% | High review volume and fast negative-response rate signal better operations |
| State availability | 5% | A program you can't access is irrelevant |
| Public clinical evidence | 5% | Published observational data with clear limitations is more useful than unsourced marketing claims |
Where Does Each Provider Fit in the Bigger GLP-1 Market?
Gala
Mid-priced, simple-pricing compounded GLP-1 platform with all-50-state coverage and a current BBB F rating. "50,000+ success stories" per Gala's homepage (provider-stated marketing claim). No published peer-reviewed study we could verify. Smaller Trustpilot profile than Ivím but currently a 4.7 score.
Ivím Health
Higher-touch compounded and brand-name platform. Duncan et al. study published in Obesity Pillars (2025) followed 1,131 semaglutide patients over 68 weeks and reported ~21.8% average total body weight reduction. Provider-published, observational study — not randomized, not head-to-head, not a guarantee of individual results. Ivím's "46% more weight loss" marketing claim compared to a previously-published clinical trial is also explicitly not a head-to-head study. FDA misbranding warning letter received Feb 20, 2026.
Ro (the FDA-approved alternative)
The cleanest FDA-approved path in telehealth. Carries Zepbound®, Foundayo™, Wegovy®, Ozempic®, and Mounjaro® alongside other FDA-approved options. Runs an insurance concierge and offers a free GLP-1 Insurance Coverage Checker. Better fit when you want brand-name medication or insurance support.
Before You Pay Either Provider — the 14-Point Checklist
This is the part we'd want a friend to read before clicking any Buy button. Print it. Save it. Use it.
- 1Is the medication compounded or FDA-approved? Know which one you're being prescribed.
- 2What exact medication is being prescribed? Compounded semaglutide and compounded tirzepatide are different products with different costs and side-effect profiles.
- 3Which pharmacy actually dispenses it? Ask for the name.
- 4Is the pharmacy a 503A or 503B? Is it licensed to ship to your state?
- 5Does the price change at higher doses? Some providers escalate cost as your dose escalates; some don't.
- 6Is there a required program or membership fee on top of the medication? (For Ivím, yes — about $75/month after the first free month. For Gala, no separate fee beyond the subscription.)
- 7What's the total cost through the first 90 days? Not the headline price — the all-in total.
- 8Can you cancel mid-term? (For Ivím multi-month plans, no.)
- 9What's the deadline to cancel before the next billing cycle? (Gala: 72 hours. Ivím: 48 hours before renewal.)
- 10What happens if a provider decides you don't qualify after you've paid? (Gala: full refund. Ivím: case by case; medication is non-refundable.)
- 11What happens to your medication if your shipment is damaged, lost, or stolen?
- 12Are labs required, and do they cost extra?
- 13Is HSA/FSA accepted at checkout? Verify with your specific plan administrator — eligibility varies by plan.
- 14Who do you contact for side effects, dosing questions, or emergencies?
If a provider can't answer all 14 clearly before you pay, slow down.
Frequently Asked Questions
Is Gala GLP-1 the same as Ivim Health?
No. They're separate companies with different pricing structures, plan lengths, medication menus, and care models. Gala is operated by AI Coaching Inc. (dba Gala GLP-1) out of Wilmington, Delaware. Ivím was founded in 2021 by Dr. Taylor Kantor, Anthony Kantor, and Kelly Kantor, and operates as Ivim Services LLC out of Columbus, Ohio.
Which is cheaper, Gala or Ivim?
It depends on plan length and medication. For Gala's $199/mo 3-month plan, three months total about $597. For Ivím's 4-month semaglutide package, the all-in (medication plus 3 months of program fee) totals about $724, or about $181 per month. For tirzepatide, Gala is cheaper at every comparable plan length. Gala has no separate program fee; Ivím charges $74.99/month after the first free month.
Does Ivim Health have a hidden program fee?
It's not exactly hidden, but it's easy to miss. The $74.99/month program fee is on Ivím's pricing page, but the headline number in ads is the medication price. The first month is free; the fee starts in month 2. On a 4-month medication plan, you'll pay 3 months of program fee ($225) on top of the medication cost.
Does Gala GLP-1 have a hidden program fee?
No separate program fee is disclosed beyond the subscription price. Gala describes the offering as a 'Subscription Service' — the platform access and medication are bundled into the monthly subscription.
Is Gala GLP-1 legit?
Based on its public business profile, terms, refund policy, and Trustpilot footprint, Gala is a real telehealth company with paying customers. Its BBB profile currently shows an F rating with 15 unanswered complaints and no BBB accreditation — that's a real complaint-handling signal you should weigh before signing up. Real, but not risk-free.
Is Ivim Health legit?
Based on its public business profile, peer-reviewed observational research, Trustpilot footprint of ~37,232 reviews at 4.9 stars, and BBB A+ accreditation since 2/28/2023, Ivím is a real, established telehealth company. The FDA issued a warning letter on February 20, 2026 for misbranding (a labeling and marketing violation — not a contamination or sterility finding). Real, but not without regulatory context.
Is Ivim Health available in every state?
No. Ivím's help center states it provides services in 49 states plus Washington, D.C. Mississippi is excluded. Gala states it serves all 50 states. Verify state availability at checkout.
Can I cancel Gala GLP-1?
Yes, anytime — but you need to request cancellation at least 72 hours before your next billing date. Cancellation does not automatically trigger a refund for the current billing cycle. A full refund is available if a provider determines you're medically disqualified.
Can I cancel Ivim Health?
You can cancel after your current program term ends (programs are typically 2, 4, 6, or 12 months). You cannot cancel mid-term. Cancellation requests must be made at least 48 hours before renewal. The $74.99/month program fee can be canceled separately from the medication plan.
Are compounded GLP-1 medications safe?
Compounded medications are not FDA-approved finished drug products. They're prepared by licensed compounding pharmacies and have not been reviewed by the FDA for safety, effectiveness, or quality. The FDA has reported 605 compounded semaglutide adverse-event reports and 545 compounded tirzepatide reports as of July 31, 2025, and noted underreporting is likely. Compounded doesn't automatically mean unsafe, but it's not the same regulatory bar as FDA-approved medication. Talk to a licensed clinician before starting.
What if I want FDA-approved medication like Wegovy® or Zepbound®?
Neither Gala nor Ivim is the cleanest regulatory path for FDA-approved medication. Ro publicly carries Zepbound®, Foundayo™, Wegovy®, Ozempic®, and Mounjaro®, runs an insurance concierge, and offers a free GLP-1 Insurance Coverage Checker. Ro Body starts at $39 for the first month, then as low as $74/month with the annual plan paid upfront. Medication is billed separately.
Will my insurance cover Gala or Ivim?
Gala is cash-pay; insurance is not used. Ivím's program fee is cash-pay, but the company submits prior-authorization paperwork for brand-name FDA-approved medications to many private insurance plans (generally not Medicare or Medicaid). Compounded medication is cash-pay at both providers; HSA/FSA may apply to the medication portion — verify with your plan administrator.
Are results guaranteed?
No. Individual results vary. GLP-1 medications can produce significant weight loss, but they require consistent use, lifestyle changes, and provider oversight. No provider, including Gala or Ivím, can guarantee a specific weight-loss outcome.
The Final Verdict — and Where to Go Next
Choose Gala GLP-1 if:
You want one subscription price ($149–$199 depending on plan and track), no separate program fee, the ability to cancel before any billing cycle (72-hour deadline), and access in all 50 states. You're okay with a lighter-touch async support model and you've weighed the BBB rating context.
Prescription required after clinical review; final price confirmed at checkout. Sponsored affiliate link.
Choose Ivím Health if:
You can commit to a 4- or 12-month plan, you want a higher-touch program with weekly provider check-ins and unlimited visits, and you value the larger Trustpilot footprint and published observational research. You're comfortable with the February 2026 FDA misbranding warning letter context and the program-fee math.
Not an affiliate link.
Choose Ro instead if:
You want FDA-approved brand-name medication (Wegovy®, Zepbound®, Foundayo™, Ozempic®, Mounjaro®) and insurance prior-authorization support.
Get started for $39, then as low as $74/mo with annual plan paid upfront. Medication billed separately. Prescription required. Sponsored affiliate link.
Still on the fence? The harder part isn't choosing a provider — it's giving yourself permission to start. Both Gala and Ivím are real telehealth programs with real customers and real flaws. Use the checklist, verify the checkout terms, and make the call.
6 questions. Matches you to the GLP-1 program that fits your budget, state, and goals.
Related Guides on Weight Loss Provider Guide
- → Is Gala GLP-1 FDA-Approved? (2026 Regulatory Guide)
- → Is Gala GLP-1 Covered by Insurance? (2026)
- → Best GLP-1 Providers If Insurance Denies Wegovy (2026)
- → Best Foundayo Providers That Accept Insurance (2026)
- → Eden vs Zealthy (2026): Pricing, Risks & Honest Verdict
- → GLP-1 Weight Loss Calculator: Wegovy, Zepbound & Foundayo (2026)
- → Find My GLP-1 Path — free 60-second personalized quiz